Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs

por Brookes, K, Cummings, J, Backen, A, Greystoke, A, Ward, T, Jayson, G C, Dive, C
Publicado 2010

Biomarkers of apoptosis

por Ward, T H, Cummings, J, Dean, E, Greystoke, A, Hou, J M, Backen, A, Ranson, M, Dive, C
Publicado 2008

Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancers

por Zhou, C., O’Connor, J., Backen, A., Valle, J.W., Bridgewater, J., Dive, C., Jayson, G.C.
Publicado 2022

Heparan sulphate synthetic and editing enzymes in ovarian cancer

por Backen, A C, Cole, C L, Lau, S C, Clamp, A R, McVey, R, Gallagher, J T, Jayson, G C
Publicado 2007

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

por Khoja, L, Backen, A, Sloane, R, Menasce, L, Ryder, D, Krebs, M, Board, R, Clack, G, Hughes, A, Blackhall, F, Valle, J W, Dive, C
Publicado 2012